Genome-wide metabolite quantitative trait loci analysis (mQTL) in red blood cells from volunteer blood donors.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
12 2022
Historique:
received: 22 09 2022
revised: 08 11 2022
accepted: 10 11 2022
pubmed: 18 11 2022
medline: 6 1 2023
entrez: 17 11 2022
Statut: ppublish

Résumé

The red blood cell (RBC)-Omics study, part of the larger NHLBI-funded Recipient Epidemiology and Donor Evaluation Study (REDS-III), aims to understand the genetic contribution to blood donor RBC characteristics. Previous work identified donor demographic, behavioral, genetic, and metabolic underpinnings to blood donation, storage, and (to a lesser extent) transfusion outcomes, but none have yet linked the genetic and metabolic bodies of work. We performed a genome-wide association (GWA) analysis using RBC-Omics study participants with generated untargeted metabolomics data to identify metabolite quantitative trait loci in RBCs. We performed GWA analyses of 382 metabolites in 243 individuals imputed using the 1000 Genomes Project phase 3 all-ancestry reference panel. Analyses were conducted using ProbABEL and adjusted for sex, age, donation center, number of whole blood donations in the past 2 years, and first 10 principal components of ancestry. Our results identified 423 independent genetic loci associated with 132 metabolites (p < 5×10

Identifiants

pubmed: 36395887
pii: S0021-9258(22)01149-8
doi: 10.1016/j.jbc.2022.102706
pmc: PMC9763692
pii:
doi:

Substances chimiques

LPCAT3 protein, mouse EC 2.3.1.23
1-Acylglycerophosphocholine O-Acyltransferase EC 2.3.1.23

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102706

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL146442
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL161004
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148151
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21 HL150032
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149714
Pays : United States
Organisme : NIGMS NIH HHS
ID : RM1 GM131968
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest Though unrelated to the contents of this manuscripts, the authors declare that A. D. is a founder of Omix Technologies Inc and Altis Biosciences LLC. A. D. is SAB members for Hemanext Inc. and FORMA Therapeutics Inc. A. D. is a consultant for Rubius Therapeutics. J. C. Z. is a consultant for Rubius Therapeutics and a founder of Svalinn Therapeutics. All other authors have no conflicts of interests to disclose.

Auteurs

Amy Moore (A)

Division of Biostatistics and Epidemiology, RTI International, Atlanta, Georgia, USA.

Michael P Busch (MP)

Vitalant Research Institute, San Francisco, California, USA.

Karolina Dziewulska (K)

Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Richard O Francis (RO)

Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.

Eldad A Hod (EA)

Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.

James C Zimring (JC)

Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Angelo D'Alessandro (A)

Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO, USA. Electronic address: angelo.dalessandro@ucdenver.edu.

Grier P Page (GP)

Division of Biostatistics and Epidemiology, RTI International, Atlanta, Georgia, USA. Electronic address: gpage@rti.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH